Thus, recipients of β2i/MECL-1&β5i/LMP7-deficient T-cells develop colitis six weeks after T-cell transfer, with even higher histological scores and higher quantities of IL17α in the spleens than detected in recipients of wt CD4+ T-cells, despite enhanced numbers and frequencies of iTregs. Here, IL17A is linked to colitis.